bioAffinity Technologies
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,269 | $1,854 | $2,208 | $2,350 |
Gross Profit | 252 | 485 | 645 | 910 |
EBITDA | -3,908 | -2,482 | -2,788 | -1,825 |
EBIT | -4,021 | -2,636 | -2,941 | -1,976 |
Net Income | -4,060 | -2,660 | -2,967 | -2,001 |
Net Change In Cash | 1,269 | 1,854 | 2,208 | 2,350 |
Free Cash Flow | -2,660 | -1,692 | -1,677 | -1,718 |
Cash | 802 | 444 | 1,105 | 756 |
Basic Shares | 800 | 541 | 413 | 413 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $9,362 | $2,532 | $4 | $1 |
Gross Profit | 3,379 | 791 | 4 | -4 |
EBITDA | -8,330 | -7,629 | -5,609 | -2,202 |
EBIT | -8,935 | -7,878 | -5,619 | -2,206 |
Net Income | -9,040 | -7,937 | -8,154 | -6,326 |
Net Change In Cash | 9,362 | 2,532 | 4 | 1 |
Free Cash Flow | -7,343 | -6,060 | -4,290 | -2,048 |
Cash | 1,105 | 2,821 | 11,413 | 1,360 |
Basic Shares | 404 | 291 | 149 | 245 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.17 |
2025-03-31 | -$0.19 |
2024-12-31 | -$0.19 |
